NHS should invest in digital, AI, and robotics trainingThe Topol Review of the training needs of the future NHS workforce has published its recommendations – including Share XNHS should invest in digital, AI, and robotics traininghttps://pharmaphorum.com/news/nhs-should-invest-in-digital-ai-and-robotics-training/
What will a no-deal Brexit mean for pharma and healthcare?Britons are bracing themselves for the UK’s imminent departure from the European Union. A worst-case scenario would see Share XWhat will a no-deal Brexit mean for pharma and healthcare?https://pharmaphorum.com/views-and-analysis/what-will-a-no-deal-brexit-mean-for-pharma-and-healthcare/
Cost concerns with the new NHS pricing schemeA new pricing scheme, which took effect this month, has raised the cap on NHS spending on branded Share XCost concerns with the new NHS pricing schemehttps://pharmaphorum.com/views-analysis-market-access/cost-concerns-with-the-new-nhs-pricing-scheme/
NHS faces uphill battle in prevention – surveyA new survey has revealed confusion amongst the UK public on how to maintain a healthy lifestyle, suggesting Share XNHS faces uphill battle in prevention – surveyhttps://pharmaphorum.com/news/nhs-uphill-battle-prevention-survey/
Mental health services falling behind rest of NHS – reportMental health services in the UK are falling behind physical health services because of outdated commissioning services in Share XMental health services falling behind rest of NHS – reporthttps://pharmaphorum.com/news/mental-health-services-falling-behind-rest-of-nhs-report/
NHS looks to digital and genomics to secure its futureGenomics, digital tech and artificial intelligence are at the forefront of the government’s long term plan for the Share XNHS looks to digital and genomics to secure its futurehttps://pharmaphorum.com/news/nhs-digital-genomics-future/
NHS U-turns on Afinitor for TSC-related epilepsyNHS England has reversed a previous decision and will be funding Novartis’ Afinitor (everolimus) for TSC-related refractory epilepsy Share XNHS U-turns on Afinitor for TSC-related epilepsyhttps://pharmaphorum.com/news/nhs-u-turns-afinitor-tsc-related-epilepsy/
NICE reveals new standards for digital techNICE has published new standards setting out the requirements needed to develop digital health technologies for the NHS Share XNICE reveals new standards for digital techhttps://pharmaphorum.com/news/nice-reveals-new-standards-for-digital-tech/
NHS lags best performers in cancer care – reportThe performance of NHS cancer services in England is lagging behind those of comparable countries, according to a Share XNHS lags best performers in cancer care – reporthttps://pharmaphorum.com/news/nhs-lags-best-performers-in-cancer-care-report/
